FDA panel recommends easing access to unapproved peptide drugs favored by wellness influencers, despite concerns over safety and effectiveness.

FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.

Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the way for easier access.